
1. proc natl acad sci u a. 2009 sep 15;106(37):15837-42. doi:
10.1073/pnas.0903419106. epub 2009 aug 17.

heme oxygenase-1 affords protection noncerebral forms severe malaria.

seixas e(1), gozzelino r, chora a, ferreira a, silva g, larsen r, rebelo s,
penido c, smith nr, coutinho a, soares mp.

author information: 
(1)instituto gulbenkian de ciÃªncia, oeiras, portugal.

comment in
    proc natl acad sci u a. 2009 sep 15;106(37):15525-6.

infection plasmodium, causative agent malaria, associated with
hemolysis therefore release hemoglobin rbc. inflammatory
conditions, cell-free hemoglobin oxidized, releasing heme prosthetic
groups producing deleterious free heme. demonstrate survival 
a plasmodium-infected host relies strictly ability prevent the
cytotoxic effects free heme via expression heme-catabolyzing enzyme
heme oxygenase-1 (ho-1; encoded hmox1 gene). infected plasmodium
chabaudi chabaudi (pcc), wild-type (hmox1(+/+)) balb/c mice resolved infection
and restored homeostasis thereafter (0% lethality). contrast, ho-1 deficient
(hmox1(-/-)) balb/c mice developed lethal form hepatic failure (100%
lethality), similar one occurring pcc-infected dba/2 mice (75%
lethality). expression ho-1 suppresses pro-oxidant effects free heme,
preventing sensitizing hepatocytes undergo tnf-mediated programmed
cell death apoptosis. cytoprotective effect, inhibits the
development hepatic failure pcc-infected mice without interfering with
pathogen burden, mimicked pharmacological antioxidants as
n-acetylcysteine (nac). administered therapeutically, i.e., pcc
infection, nac suppressed development hepatic failure pcc-infected
dba/2 mice (0% lethality), without interfering pathogen burden. in
conclusion, describe mechanism host defense plasmodium infection,
based tissue cytoprotection free heme limiting disease severity
irrespectively parasite burden.

doi: 10.1073/pnas.0903419106 
pmcid: pmc2728109
pmid: 19706490  [indexed medline]

